The Point of Care Technology Research Network develops technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.

POCTRN and COVID-19

In response to COVID-19 pandemic, POCTRN has helped to launch the Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. We have also curated a number resources and additional funding opportunities on our resources page.

Explore RADx

RADx Tech
RADx Tech II
RADx Tech High-Performance Tests
RADx Tech Accessible Tests
ITAP
Webinars

Atlanta Center for Microsystems Engineered Point-of-Care Technologies

Focus: To develop and translate microsystems-engineered technologies including microchip-enabled devices that include microelectromechanical systems (MEMs)-based sensors, microfluidics, and smartphone-based systems.

Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases

Focus: To develop and test the accuracy, acceptability, and optimal implementation of point-of-care tests for sexually transmitted diseases in diverse care delivery contexts both in the United States and in resource-limited settings.

Center for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern

Focus: To support the development of a pipeline of Point-of-Care Technologies designed to meet the clinical needs of people who live with HIV/AIDS in low- and middle-income countries.

Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases

Focus: To support development and testing of promising “late-stage” point of care technologies that can be rapidly deployed to enhance the diagnosis, monitoring, management and/or treatment of heart, lung, blood and sleep disorders.

Center news

null Blueprint MedTech Cycle 2 Annoucement

Funding Opportunity: Blueprint MedTech Spring Award Competition

CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, have started accepting pre-proposals from academic and industry applicants who have emerging technologies that aim to improve the prevention, diagnosis, and/or treatment of disorders involving the nervous system or consequences of such a disease or injury.

Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization.

A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space.

Program Details: